1-25 DIHYDROXYVITAMIN D3 OF VITAMIN D - ANVISA Registration 10339840487

Access comprehensive regulatory information for 1-25 DIHYDROXYVITAMIN D3 OF VITAMIN D in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10339840487 and manufactured by DIASORIN INC.. The registration is held by DIASORIN LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including IDS IMMUNODIAGNOSTIC SYSTEM LTD, WUHAN HUAMEI BIOTECH CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10339840487
Registration Details
ANVISA Registration Number: 10339840487
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

LIAISON® XL 1,25 Dihydroxyvitamin D Controls
Risk Class II

Registration Details

10339840487

25351269630201885

01896764000170

Company Information

DIASORIN INC.
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jul 16, 2018

VIGENTE

09/18/2025 19:00:01